Loading...
XTSE
CRRX
Market cap158mUSD
Jul 09, Last price  
3.55CAD
1D
1.14%
1Q
-7.07%
Jan 2017
-69.92%
IPO
-56.71%
Name

CareRx Corp

Chart & Performance

D1W1MN
XTSE:CRRX chart
P/E
8.62
P/S
0.61
EPS
0.41
Div Yield, %
1.13%
Shrs. gr., 5y
26.05%
Rev. gr., 5y
17.95%
Revenues
370m
+0.96%
12,321,11614,251,04515,795,22636,623,00062,482,000200,992,000436,651,000455,864,000308,074,000162,421,000167,363,000168,967,000123,742,000124,626,000162,196,000262,630,000381,727,000370,746,000366,714,000370,241,000
Net income
26m
P
49,468754,686952,1861,640,0004,328,000-8,982,000-7,258,000-91,091,000-57,447,00046,083,000-19,677,0001,846,000-31,093,000-45,677,000-18,183,000-22,730,000-34,353,000-5,405,000-4,501,00026,127,000
CFO
28m
-27.52%
86,696915,891433,2623,031,0005,945,0007,598,00015,314,00020,204,00019,719,00029,447,0001,700,00016,073,0006,592,0006,355,000229,0007,269,00022,333,00027,375,00037,991,00027,536,000
Dividend
Dec 23, 20250.02 CAD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

CareRx Corporation, alongside its affiliated entities, delivers specialized pharmaceutical services specifically for Canada's senior population. The company operates a comprehensive network of pharmacy fulfillment centers. These centers are crucial for dispensing chronic medications and offering a variety of other advanced clinical pharmacy solutions. CareRx caters to approximately 50,000 residents across roughly 900 diverse senior living environments, including long-term care facilities, retirement residences, assisted living centers, and communal group homes. Originally established as Centric Health Corporation, the company officially rebranded to CareRx Corporation in June 2020. Tracing its origins back to its incorporation in 2001, CareRx Corporation maintains its primary operational base in Toronto, Canada.
URL
https://www.carerx.ca/
IPO date
Sep 04, 2002
Employees
1,444
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT